Crescent Ebitda from 2010 to 2024

CCAP Stock  USD 19.22  0.16  0.84%   
Crescent Capital EBITDA yearly trend continues to be relatively stable with very little volatility. EBITDA is likely to grow to about 88.3 M this year. During the period from 2010 to 2024, Crescent Capital EBITDA destribution of quarterly values had range of 90.5 M from its regression line and mean deviation of  27,813,340. View All Fundamentals
 
EBITDA  
First Reported
2015-06-30
Previous Quarter
43.6 M
Current Value
37.1 M
Quarterly Volatility
747.9 B
 
Yuan Drop
 
Covid
Check Crescent Capital financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Crescent Capital's main balance sheet or income statement drivers, such as Tax Provision of 260.3 K, Interest Income of 178.4 M or Interest Expense of 57.6 M, as well as many indicators such as Price To Sales Ratio of 3.44, Dividend Yield of 0.0521 or PTB Ratio of 0.8. Crescent financial statements analysis is a perfect complement when working with Crescent Capital Valuation or Volatility modules.
  
Check out the analysis of Crescent Capital Correlation against competitors.

Latest Crescent Capital's Ebitda Growth Pattern

Below is the plot of the Ebitda of Crescent Capital BDC over the last few years. It is Crescent Capital's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Crescent Capital's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Crescent Ebitda Regression Statistics

Arithmetic Mean25,582,396
Geometric Mean10,888,043
Coefficient Of Variation134.21
Mean Deviation27,813,340
Median11,768,693
Standard Deviation34,335,241
Sample Variance1178.9T
Range90.5M
R-Value0.88
Mean Square Error285.8T
R-Squared0.77
Significance0.000015
Slope6,758,359
Total Sum of Squares16504.7T

Crescent Ebitda History

202488.3 M
202384.1 M
202245.4 M
202184.6 M
202030 M
201929.6 M
20188.2 M

About Crescent Capital Financial Statements

Crescent Capital shareholders use historical fundamental indicators, such as Ebitda, to determine how well the company is positioned to perform in the future. Although Crescent Capital investors may analyze each financial statement separately, they are all interrelated. The changes in Crescent Capital's assets and liabilities, for example, are also reflected in the revenues and expenses on on Crescent Capital's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
EBITDA84.1 M88.3 M

Pair Trading with Crescent Capital

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Crescent Capital position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crescent Capital will appreciate offsetting losses from the drop in the long position's value.

Moving together with Crescent Stock

  0.71DHIL Diamond Hill InvestmentPairCorr
  0.69DIST Distoken AcquisitionPairCorr
  0.64AC Associated CapitalPairCorr

Moving against Crescent Stock

  0.39PT Pintec TechnologyPairCorr
The ability to find closely correlated positions to Crescent Capital could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Crescent Capital when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Crescent Capital - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Crescent Capital BDC to buy it.
The correlation of Crescent Capital is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Crescent Capital moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Crescent Capital BDC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Crescent Capital can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Crescent Stock Analysis

When running Crescent Capital's price analysis, check to measure Crescent Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crescent Capital is operating at the current time. Most of Crescent Capital's value examination focuses on studying past and present price action to predict the probability of Crescent Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crescent Capital's price. Additionally, you may evaluate how the addition of Crescent Capital to your portfolios can decrease your overall portfolio volatility.